Clinical characteristics | Age group of STEMI patients | ||||
Group-I n = 10 | Group-II n = 96 | Group-III n = 94 | |||
Age, mean ± SD | 36.5 ± 3.4 | 54.3 ± 8.2 | 68.4 ± 7.2 | ||
Female, n (%) | 2 (20%) | 13 (13.5%) | 20 (21.3%) | ||
History of myocardial infarction, n (%) | 2 (20%) | 4 (4.2%) | 0 (0%) | ||
Risk factors | |||||
Dyslipidemia, n (%) | 2 (20%) | 22 (22.9%) | 15 (16%) | ||
Diabetes, n (%) | 0 (0%) | 34 (35.4%) | 41 (43.6%) | ||
Hypertension, n (%) | 1 (10%) | 34 (35.4%) | 42 (44.7%) | ||
Smoker, n (%) | 4 (40%) | 48 (50%) | 30 (31.9%) | ||
Previous myocardial infarction | 0 (0%) | 4 (4.2%) | 5 (5.3%) | ||
Chronic kidney disease, n (%) | 0 (0%) | 0 (0%) | 2 (2.1%) | ||
Cerebrovascular accident, n (%) | 0 (0%) | 3 (3.1%) | 2 (2.1%) | ||
Peripheral vascular disease, n (%) | 1 (10%) | 3 (3.1%) | 1 (1.1%) | ||
KILLIP class 3/4, n (%) | 1 (10%) | 9 (9.4%) | 16 (17.0%) | ||
Severe left ventricular dysfunction, n (%) | 0 (0%) | 2 (2.1%) | 3 (3.1%) | ||
Ventricular septal rupture, n (%) | 0 (0%) | 1 (1%) | 1 (1.1%) | ||